Rhinorus, spray 0.05%, 10ml

Composition

>

1 ml contains:

Active ingredient:

xylometazoline hydrochloride 0.5 mg;

Auxiliary substances:

benzalkonium chloride,

sodium chloride,

disodium edetate,

sodium dihydrogen phosphate dihydrate,

sodium hydrophosphate dodecahydrate,

eucalyptus oil,

d/i water.

Pharmacological action

Vasoconstrictor drug for topical use in ENT practice.

Xylometazoline (imidazoline derivative) is an alpha-adrenomimetic, causes narrowing of the blood vessels of the nasal mucosa, eliminating its edema and hyperemia, restores patency of the nasal passages, facilitates nasal breathing and improves the discharge of nasal secretions in rhinitis (runny nose) of various origins.

The effect of the drug occurs a few minutes after its application and lasts up to 10 hours.

Indications

• acute rhinitis (including against the background of acute respiratory diseases and allergic rhinitis);
• sinusitis;
• eustachiitis;
• runny nose with allergies and colds;
• otitis media (as part of combination therapy to reduce swelling of the nasopharyngeal mucosa);
• to facilitate rhinoscopy;
• preparation of patients for diagnostic manipulations in the nasal passages.

Contraindications

• acute rhinitis (including against the background of acute respiratory diseases and allergic rhinitis);
• sinusitis;
• eustachiitis;
• runny nose with allergies and colds;
• otitis media (as part of combination therapy to reduce swelling of the nasopharyngeal mucosa);
• to facilitate rhinoscopy;
• preparation of patients for diagnostic manipulations in the nasal passages.

Side effects

Local reactions:  with frequent and/or prolonged use – irritation and/or dryness of the nasopharyngeal mucosa, burning, paresthesia, sneezing, hypersecretion; rarely – swelling of the nasal mucosa.

Systemic reactions:  vomiting, headache, palpitations, increased blood pressure, insomnia, visual impairment, depression (with prolonged use of high doses).

Interaction

It is possible to increase the systemic effect with simultaneous use of monoamine oxidase (MAO) inhibitors and tricyclic antidepressants.

How to take, course of use and dosage

Adults and children over 6 years of age – 1 injection of 0.1% nasal spray in each nasal passage 3 times / day. If necessary, you can repeat the injection (no more than two injections at a time).

Children from 2 to 6 years – 1 injection of 0.05% nasal spray in each nasal passage 1-2 times / day.

Do not use the drug more than 3 times a day. The duration of treatment is no more than 5-7 days (without a break).

After the end of therapy, the drug can be prescribed again only after a few days.

The duration of use of the drug in children is determined by the doctor.

Overdose

Symptoms:  increased side effects.

Treatment:  symptomatic under the supervision of a doctor.

Special instructions

Rhinorus is used with caution in patients with cardiovascular insufficiency, arterial hypertension, hyperthyroidism. The drug Rhinorus is undesirable to use for a runny nose for a long time because of the danger of destruction of the nasal mucosa, which leads to a constant feeling of nasal congestion.

Form of production

Rhinorus nasal spray

Storage conditions

In a dry place, protected from light, at a temperature not exceeding 25 °C.

Shelf

life is 2 years.

Active ingredient

Xylometazoline

Dosage form

nasal spray

Description

Children’s forms